相关实验视频
Updated: Jun 22, 2025
07:47
Studying the Role of Alveolar Macrophages in Breast Cancer Metastasis
Published on: June 26, 2016
9.7K
[恶性血液病中CAR巨细胞的研究进展]
1Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
|July 1, 2024
概括
化学抗原受体巨细胞 (CAR-M) 疗法在治疗血液癌症方面表现有前途. 本综述涵盖了CAR-M的开发,临床试验以及血液恶性瘤的未来潜力.
科学领域:
- 免疫治疗是一种免疫疗法.
- 细胞疗法细胞疗法
- 血液瘤学 血液瘤学
背景情况:
- 化学抗原受体 (CAR) 技术已经彻底改变了癌症治疗.
- 巨细胞正在成为向癌症治疗的强有力的效应细胞.
- 卡尔-M疗法代表了一种利用免疫细胞对抗癌症的新方法.
研究的目的:
- 审查CAR-M疗法的发展史.
- 讨论CAR-M治疗在恶性血液病中的应用.
- 在临床环境中分析CAR-M疗法的优势和挑战.
主要方法:
- 关于CAR-M疗法发展的文献综述.
- 对血液恶性瘤中CAR-M临床试验数据的分析.
- 评估当前的挑战和未来的前景.
主要成果:
- 在各种血液癌症中,CAR-M疗法已经证明了临床前的疗效.
- 早期临床试验正在调查CAR-M治疗的安全性和有效性.
- 主要优势包括巨细胞效应器功能和克服抗性的潜力.
结论:
- 卡尔-M疗法在治疗恶性血液病方面具有显著的潜力.
- 需要进一步的研究和临床试验来优化CAR-M疗法.
- 应对挑战对于成功的临床翻译至关重要.
相关概念视频
01:15Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
01:01Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K